900152-72-9 Usage
Uses
Used in Pharmaceutical Industry:
Used in Research and Development:
In the realm of scientific research, REF DUPL: Fmoc-Asp(OtBu)-(Dmb)Gly-OH serves as a valuable tool for exploring the structure-activity relationships of peptides. It is used in the design and synthesis of peptides with specific properties, facilitating the discovery of new bioactive molecules with potential therapeutic applications.
Used in Peptide Drug Design:
REF DUPL: Fmoc-Asp(OtBu)-(Dmb)Gly-OH is employed as a key component in the design of peptide drugs, where its incorporation can lead to the development of molecules with enhanced pharmacokinetic and pharmacodynamic profiles. This is particularly important in the context of drug resistance and the need for innovative therapeutic strategies.
Used in Biochemistry and Molecular Biology:
REF DUPL: Fmoc-Asp(OtBu)-(Dmb)Gly-OH is also utilized in biochemical and molecular biology research to study the interactions between peptides and their target molecules, such as enzymes, receptors, or other proteins. This can provide insights into the mechanisms of action of potential therapeutic agents and contribute to the understanding of disease pathways.
Check Digit Verification of cas no
The CAS Registry Mumber 900152-72-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,0,1,5 and 2 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 900152-72:
(8*9)+(7*0)+(6*0)+(5*1)+(4*5)+(3*2)+(2*7)+(1*2)=119
119 % 10 = 9
So 900152-72-9 is a valid CAS Registry Number.
900152-72-9Relevant academic research and scientific papers
Zahariev, Sotir,Guarnaccia, Corrado,Pongor, Csaba I.,Quaroni, Luca,?ema?ar, Ma?a,Pongor, Sándor
, p. 4121 - 4124 (2006)
We developed an efficient, cost effective strategy for Fmoc-based solid phase synthesis of 'difficult' peptides and/or peptides containing Asp/Asn-Gly sequences, free of aspartimide and related products, using a peptoid methodology for the preparation of N-substituted glycines.
